Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $2 | $4 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$0 | $0 |
| Other Curr. Assets | $0 | $0 | $2 | $11 |
| Total Curr. Assets | $0 | $2 | $5 | $15 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $4 | $21 | $21 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | -$4 | $0 | $0 |
| Other NC Assets | $0 | $2 | $2 | -$21 |
| Total NC Assets | $4 | $2 | $23 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4 | $4 | $28 | $16 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $0 |
| Total Curr. Liab. | $1 | $0 | $2 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4 | $0 | $2 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $63 | $62 | $57 | $12 |
| Retained Earnings | -$77 | -$72 | -$44 | -$20 |
| AOCI | $14 | $14 | $13 | $13 |
| Other Equity | $0 | $0 | $0 | $10 |
| Total Equity | $0 | $4 | $27 | $15 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | $0 |
| Total Liab. & Tot. Equity | $4 | $4 | $28 | $16 |
| Net Debt | -$0 | -$2 | -$4 | -$4 |